从高血压疾病与同时存在的高脂血症的长期死亡趋势:美国,1999-2023年
Naveed Ahmad1, Mian Sajjad Ali1, Ahmed W Hageen2
1From the Khyber medical college Peshawar, Khyber Pakhtunkhwa, Pakistan.
Cardiology in review
|January 16, 2026
概括
结合高血压和高脂血症的死亡率在25年内在65岁以上的美国成年人中显著增加. 非西班牙裔黑人个人和男性的发病率最高,突出了心血管结果的差异.
科学领域:
- 心血管疾病流行病学
- 公共卫生 公共卫生
- 老年学是一门学科.
背景情况:
- 高血压疾病和高脂血症是全球心血管疾病发病率和死亡率的主要原因.
- 关于高血压和高脂血症联合发生的死亡率趋势的长期数据有限.
研究的目的:
- 分析与高血压疾病和高脂血症在65岁及以上的美国成年人同时发生的长期死亡趋势.
- 确定与这些综合疾病相关的死亡率的人口差异.
主要方法:
- 利用CDC WONDER 1999-2023年的数据,以多种原因导致高血压疾病 (I10-I15) 和高脂血症 (E78) 的死亡.
- 根据年龄调整的死亡率 (AAMR) 和使用Joinpoint回归计算的年平均百分比变化.
- 按性别,种族/种族,城市化,地区和年龄分层分析.
主要成果:
- 确定的死亡人数为960,024人;AAMR从1999年的6.56人增加到2023年的每10万人中163人.
- 最高的AAMR是在2021年观察到的 (每10万人中有164人).
- 非西班牙裔黑人个人和男性的死亡率最高,随着时间的推移,在两种性别中都观察到一致的增加.
结论:
- 在过去的25年中,美国老年人中,联合高血压和高脂血症的死亡率显著上升.
- 死亡率趋势的显著人口差异需要公平获得医疗保健和综合降低风险的战略.
- 解决这些差异对于改善弱势群体心脏代谢结果至关重要.
更多相关视频
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
8.0K
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
4.4K
相关概念视频
01:29Hypertension II: Pathophysiology
803
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
803
01:26Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
471
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
471
01:28Hypertension I: Introduction
745
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
745
01:21Drug Dosing: Obese Patients
225
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
225
01:30Coronary Artery Disease I: Introduction
890
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
890